Gudcef Plus Tablet contains Cefpodoxime Proxetil 200mg and Ofloxacin 200mg, combining a third-generation cephalosporin antibiotic with a fluoroquinolone antibiotic to provide broad-spectrum antibacterial activity. Cefpodoxime Proxetil acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death, while Ofloxacin interferes with bacterial DNA gyrase and topoisomerase IV, preventing DNA replication and transcription. This combination is effective against a wide range of gram-positive and gram-negative pathogens, making it suitable for treating respiratory tract infections, urinary tract infections, skin and soft tissue infections, and sexually transmitted infections. Gudcef Plus is indicated for infections caused by susceptible strains of bacteria, including those resistant to single-agent therapy. The tablet should be administered as prescribed by a healthcare professional, typically with or without food, and the full course must be completed to prevent resistance development. Caution is advised in patients with a history of hypersensitivity to cephalosporins, fluoroquinolones, or other beta-lactam antibiotics. Potential side effects include gastrointestinal disturbances, hypersensitivity reactions, and central nervous system effects such as dizziness or headache. Use during pregnancy and lactation should be under medical supervision. Regular monitoring and adherence to prescribed dosage enhance therapeutic efficacy and safety.